New offering designed to combine proactive monitoring and personalized engagement.
Cold chain solutions company AeroSafe Global has unveiled its patient and provider services, which comprise the organization's control tower support with personalized engagement.
Control tower is used by manufacturers and specialty pharma to validate safe delivery by monitoring, measuring, and modeling transit data. According to AeroSafe Global, once therapies are delivered, its personalized engagement service provides opportunities to extend information, resources, branding, and surveys to healthcare providers and patients.
"Our recently launched 'patient and provider services' offer our customers visibility and assurance of safe delivery, and enable them to engage with patients in new ways," says Jay McHarg, CEO of AeroSafe Global. "Through timely, personalized information, education, and support, we strive to enhance the patient experience and ultimately improve outcomes."
Reference: Cold Chain as a Service (CCaaS) Leader Offers Proactive Monitoring and Personalized Engagement. LAS VEGAS, May 1, 2023/PRNewswire.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.